Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.520
-0.080 (-5.00%)
At close: Aug 17, 2026, 4:00 PM EDT
1.500
-0.020 (-1.32%)
After-hours: Aug 17, 2026, 7:30 PM EDT
Neumora Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Neumora Therapeutics stock has a consensus rating of "Buy" and an average price target of $6.28. The average 1-year stock price forecast is 313.16% higher than the current stock price, while the lowest is $3.00 (+97.37%) and the highest is $14 (+821.05%).
Price Target: $6.28 (+313.16%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Neumora Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +360.53% | Aug 17, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $4 | Buy | Reiterates | $4 | +163.16% | Aug 17, 2026 |
| Needham | Needham | Buy Reiterates $5 | Buy | Reiterates | $5 | +228.95% | Aug 14, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 14, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +228.95% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
1.50M
EPS This Year
-0.91
from -1.45
EPS Next Year
-0.74
from -0.91
EPS and Forward PE are based on non-GAAP adjusted numbers.